European Journal of Therapeutics

European Journal of Therapeutics (Eur J Ther) is the double-blind peer-reviewed, open-access, international publication organ of the Gaziantep University School of Medicine. The journal is a quarterly publication, published on March, June, September, and December and its publication language is English. European Journal of Therapeutics will be published bi-monthly, commencing in 2024 (February, April, June, August, October and December). European Journal of Therapeutics aims to contribute to the international literature by publishing original clinical and experimental research articles, short communication, review articles, technical notes, and letters to the editor in the fields of medical sciences. The journal’s target audience includes researchers, physicians and healthcare professionals who are interested or working in in all medical disciplines. The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice). Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. The journal should be informed of manuscripts that have been submitted to another journal for evaluation and rejected for publication. The submission of previous reviewer reports will expedite the evaluation process. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization. Manuscripts submitted to the European Journal of Therapeutics will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions.